| interspecies interaction between organisms | GO:0044419 | 83 | 0.930 | |
| viral process | GO:0016032 | 41 | 0.919 | |
| entry into host cell | GO:0030260 | 15 | 0.905 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.888 | |
| immune effector process | GO:0002252 | 321 | 0.864 | |
| innate immune response | GO:0045087 | 157 | 0.855 | |
| negative regulation of viral genome replication | GO:0045071 | 10 | 0.849 | Human |
| response to interferon gamma | GO:0034341 | 34 | 0.745 | Human |
| viral life cycle | GO:0019058 | 36 | 0.744 | |
| movement in host environment | GO:0052126 | 15 | 0.669 | |
| negative regulation of viral entry into host cell | GO:0046597 | 10 | 0.667 | |
| defense response to virus | GO:0051607 | 68 | 0.617 | |
| response to interferon beta | GO:0035456 | 22 | 0.592 | Human |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.561 | |
| defense response to other organism | GO:0098542 | 197 | 0.488 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.444 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.435 | |
| entry into host | GO:0044409 | 15 | 0.379 | |
| interaction with host | GO:0051701 | 22 | 0.371 | |
| movement in environment of other organism involved in symbiotic interaction | GO:0052192 | 15 | 0.347 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.337 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.334 | |
| protein activation cascade | GO:0072376 | 19 | 0.311 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.306 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.291 | |
| regulation of viral entry into host cell | GO:0046596 | 12 | 0.287 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.266 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.234 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.209 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.198 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.190 | |
| defense response to bacterium | GO:0042742 | 119 | 0.190 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.185 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.183 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.178 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.175 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.170 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.165 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.163 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.156 | |
| activation of immune response | GO:0002253 | 138 | 0.152 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.151 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.139 | |
| angiogenesis | GO:0001525 | 201 | 0.124 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.122 | |
| inflammatory response | GO:0006954 | 244 | 0.120 | |
| epithelial cell development | GO:0002064 | 159 | 0.114 | |
| cytokine production | GO:0001816 | 319 | 0.113 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.112 | |
| cellular response to type i interferon | GO:0071357 | 10 | 0.110 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.109 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.106 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.103 | |
| entry into cell of other organism involved in symbiotic interaction | GO:0051806 | 15 | 0.102 | |
| muscle tissue development | GO:0060537 | 308 | 0.101 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.101 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.100 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.096 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.092 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.091 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.091 | |
| regulation of defense response | GO:0031347 | 233 | 0.091 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.090 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.089 | |
| negative regulation of immunological synapse formation | GO:2000521 | 1 | 0.088 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.086 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.086 | |
| multicellular organism growth | GO:0035264 | 161 | 0.085 | |
| cell adhesion | GO:0007155 | 329 | 0.085 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.085 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.084 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.084 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.084 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.083 | |
| gtp metabolic process | GO:0046039 | 144 | 0.081 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.079 | |
| viral entry into host cell | GO:0046718 | 15 | 0.078 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.074 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.073 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.069 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.068 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.068 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.067 | |
| endocytosis | GO:0006897 | 168 | 0.066 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.065 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.064 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.064 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.064 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.063 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.062 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.061 | |
| regulation of cell motility | GO:2000145 | 236 | 0.060 | Human |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.060 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.060 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.060 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.059 | |
| gland development | GO:0048732 | 330 | 0.057 | |
| adaptive immune response | GO:0002250 | 155 | 0.057 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.056 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.054 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.054 | |
| myoblast differentiation | GO:0045445 | 52 | 0.054 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.053 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.051 | |
| dendritic cell differentiation | GO:0097028 | 26 | 0.051 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.051 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.051 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.050 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.050 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.050 | |
| t helper 17 cell lineage commitment | GO:0072540 | 4 | 0.050 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.049 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.049 | |
| lung development | GO:0030324 | 164 | 0.048 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.048 | |
| camera type eye development | GO:0043010 | 266 | 0.047 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.045 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.045 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.045 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.045 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.044 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.044 | |
| epidermis development | GO:0008544 | 187 | 0.044 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.044 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.043 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.043 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.043 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.042 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.041 | |
| complement activation | GO:0006956 | 16 | 0.040 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.040 | |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 21 | 0.040 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.039 | |
| extracellular structure organization | GO:0043062 | 148 | 0.039 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.039 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.039 | |
| dna metabolic process | GO:0006259 | 303 | 0.038 | |
| urogenital system development | GO:0001655 | 261 | 0.038 | |
| humoral immune response | GO:0006959 | 57 | 0.037 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.037 | |
| regulation of neuron death | GO:1901214 | 134 | 0.037 | |
| endomembrane system organization | GO:0010256 | 147 | 0.037 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.037 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.036 | |
| respiratory system development | GO:0060541 | 190 | 0.036 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.036 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.036 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.036 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.036 | |
| mapk cascade | GO:0000165 | 281 | 0.036 | |
| complement activation lectin pathway | GO:0001867 | 5 | 0.035 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.035 | |
| response to nutrient levels | GO:0031667 | 109 | 0.035 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.034 | |
| regulation of cell migration | GO:0030334 | 219 | 0.034 | Human |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.033 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.033 | |
| cellular response to lipid | GO:0071396 | 145 | 0.032 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.032 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.032 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.032 | |
| oxidation reduction process | GO:0055114 | 342 | 0.032 | |
| t cell activation | GO:0042110 | 289 | 0.031 | |
| chemotaxis | GO:0006935 | 247 | 0.031 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.031 | |
| b cell differentiation | GO:0030183 | 78 | 0.031 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.031 | |
| protein maturation | GO:0051604 | 176 | 0.030 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.030 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.029 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.029 | |
| dna repair | GO:0006281 | 107 | 0.029 | |
| cellular response to peptide | GO:1901653 | 92 | 0.029 | |
| intracellular protein transport | GO:0006886 | 204 | 0.029 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.029 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.029 | |
| response to protozoan | GO:0001562 | 28 | 0.028 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.028 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.028 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.028 | |
| cognition | GO:0050890 | 149 | 0.028 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.027 | |
| regulation of secretion | GO:0051046 | 274 | 0.027 | |
| respiratory tube development | GO:0030323 | 167 | 0.026 | |
| regulation of protein transport | GO:0051223 | 163 | 0.026 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.026 | |
| fat cell differentiation | GO:0045444 | 160 | 0.026 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.026 | |
| female sex differentiation | GO:0046660 | 84 | 0.026 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.026 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.026 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.025 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.025 | |
| t cell differentiation | GO:0030217 | 174 | 0.025 | |
| response to growth factor | GO:0070848 | 198 | 0.025 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.025 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.025 | Human |
| prostate gland development | GO:0030850 | 48 | 0.024 | |
| response to steroid hormone | GO:0048545 | 56 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.024 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.024 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.024 | |
| negative regulation of defense response to virus by host | GO:0050689 | 1 | 0.024 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.024 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.024 | |
| protein localization to organelle | GO:0033365 | 185 | 0.024 | |
| sensory perception of sound | GO:0007605 | 97 | 0.023 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.023 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.023 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.023 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.023 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.023 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.023 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.023 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.023 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.023 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.022 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.022 | |
| synaptic transmission | GO:0007268 | 329 | 0.022 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.022 | |
| cellular homeostasis | GO:0019725 | 240 | 0.022 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.022 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.022 | |
| cation homeostasis | GO:0055080 | 212 | 0.022 | |
| regulation of protein binding | GO:0043393 | 60 | 0.022 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.021 | |
| response to insulin | GO:0032868 | 100 | 0.021 | |
| tube lumen cavitation | GO:0060605 | 5 | 0.021 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.021 | |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.021 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.021 | |
| gliogenesis | GO:0042063 | 141 | 0.021 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.021 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.021 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.021 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.021 | |
| cation transport | GO:0006812 | 399 | 0.021 | |
| response to radiation | GO:0009314 | 165 | 0.020 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.020 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.020 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.020 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.020 | |
| regulation of system process | GO:0044057 | 200 | 0.020 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.020 | |
| forebrain development | GO:0030900 | 302 | 0.020 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.020 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.020 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.019 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.019 | |
| circulatory system process | GO:0003013 | 197 | 0.019 | |
| t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell | GO:0002291 | 2 | 0.019 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.019 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.019 | |
| interleukin 4 mediated signaling pathway | GO:0035771 | 2 | 0.019 | |
| protein import | GO:0017038 | 101 | 0.019 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.019 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.019 | |
| regulation of protein localization | GO:0032880 | 231 | 0.019 | |
| skin development | GO:0043588 | 220 | 0.019 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.018 | |
| limb morphogenesis | GO:0035108 | 149 | 0.018 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.018 | |
| response to peptide hormone | GO:0043434 | 127 | 0.018 | |
| muscle cell development | GO:0055001 | 133 | 0.018 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.018 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.018 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.018 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.018 | |
| lateral line system development | GO:0048925 | 1 | 0.017 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.017 | |
| notch signaling pathway | GO:0007219 | 71 | 0.017 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.017 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.017 | |
| sensory system development | GO:0048880 | 3 | 0.017 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.017 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.017 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.017 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.017 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.017 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.017 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.017 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.017 | |
| negative regulation of growth | GO:0045926 | 99 | 0.017 | |
| b cell activation | GO:0042113 | 161 | 0.016 | |
| endothelium development | GO:0003158 | 45 | 0.016 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.016 | |
| regulation of viral genome replication | GO:0045069 | 13 | 0.016 | Human |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.016 | |
| sensory perception | GO:0007600 | 245 | 0.016 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.016 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.016 | |
| neural tube development | GO:0021915 | 160 | 0.016 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.016 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.016 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.016 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.016 | |
| stem cell differentiation | GO:0048863 | 268 | 0.016 | |
| learning or memory | GO:0007611 | 148 | 0.016 | |
| protein processing | GO:0016485 | 163 | 0.016 | |
| nuclear transport | GO:0051169 | 139 | 0.016 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.016 | |
| glial cell differentiation | GO:0010001 | 131 | 0.015 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.015 | |
| somitogenesis | GO:0001756 | 69 | 0.015 | Mouse |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.015 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.015 | |
| response to amino acid | GO:0043200 | 37 | 0.015 | |
| regulation of binding | GO:0051098 | 111 | 0.015 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.015 | |
| ossification | GO:0001503 | 216 | 0.015 | Human |
| positive regulation of cell activation | GO:0050867 | 158 | 0.015 | |
| wound healing | GO:0042060 | 157 | 0.015 | |
| phagocytosis | GO:0006909 | 66 | 0.015 | |
| methylation | GO:0032259 | 134 | 0.015 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.015 | |
| blood circulation | GO:0008015 | 195 | 0.015 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.015 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.015 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.015 | |
| hormone secretion | GO:0046879 | 128 | 0.015 | |
| protein secretion | GO:0009306 | 111 | 0.015 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.015 | |
| negative regulation of innate immune response | GO:0045824 | 17 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.014 | |
| amine metabolic process | GO:0009308 | 45 | 0.014 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.014 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.014 | |
| blastocyst development | GO:0001824 | 80 | 0.014 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.014 | |
| glucose homeostasis | GO:0042593 | 128 | 0.014 | |
| response to peptide | GO:1901652 | 136 | 0.014 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.014 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.014 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.014 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.014 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.014 | |
| regulation of t helper 1 cell cytokine production | GO:2000554 | 1 | 0.014 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.014 | |
| hexose transport | GO:0008645 | 56 | 0.014 | |
| plasma membrane organization | GO:0007009 | 90 | 0.014 | |
| negative regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000584 | 2 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| response to type i interferon | GO:0034340 | 12 | 0.014 | |
| maintenance of location | GO:0051235 | 89 | 0.014 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.014 | |
| positive regulation of camp dependent protein kinase activity | GO:2000481 | 3 | 0.014 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.014 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.013 | |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| response to interferon alpha | GO:0035455 | 7 | 0.013 | Human |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.013 | |
| protein polymerization | GO:0051258 | 57 | 0.013 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.013 | |
| neuromuscular process | GO:0050905 | 99 | 0.013 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.013 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.013 | |
| female gonad development | GO:0008585 | 71 | 0.013 | |
| action potential | GO:0001508 | 78 | 0.013 | |
| germ cell development | GO:0007281 | 185 | 0.013 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.013 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.013 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.013 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.013 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.013 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.013 | |
| somite development | GO:0061053 | 81 | 0.013 | Mouse |
| cellularization | GO:0007349 | 1 | 0.013 | |
| cerebral cortex development | GO:0021987 | 86 | 0.013 | |
| positive regulation of natural killer cell chemotaxis | GO:2000503 | 1 | 0.013 | |
| positive regulation of binding | GO:0051099 | 49 | 0.013 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.013 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.013 | |
| rna interference | GO:0016246 | 2 | 0.013 | |
| ear development | GO:0043583 | 200 | 0.013 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.013 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.013 | |
| male gamete generation | GO:0048232 | 285 | 0.013 | |
| leukocyte migration | GO:0050900 | 124 | 0.012 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.012 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.012 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.012 | |
| male sex differentiation | GO:0046661 | 109 | 0.012 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.012 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.012 | |
| monosaccharide transport | GO:0015749 | 58 | 0.012 | |
| gtp catabolic process | GO:0006184 | 143 | 0.012 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.012 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.012 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.012 | |
| endothelial cell development | GO:0001885 | 20 | 0.012 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.012 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.012 | |
| ovarian follicle development | GO:0001541 | 40 | 0.012 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.012 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.012 | |
| maintenance of epithelial cell apical basal polarity | GO:0045199 | 2 | 0.012 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.012 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.012 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.012 | |
| regionalization | GO:0003002 | 337 | 0.012 | Mouse |
| response to ionizing radiation | GO:0010212 | 42 | 0.012 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.012 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.012 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.012 | |
| gonad development | GO:0008406 | 141 | 0.012 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.011 | |
| isg15 protein conjugation | GO:0032020 | 4 | 0.011 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.011 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.011 | |
| cellular response to interferon alpha | GO:0035457 | 4 | 0.011 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.011 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.011 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.011 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.011 | |
| regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000583 | 2 | 0.011 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.011 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.011 | |
| response to drug | GO:0042493 | 75 | 0.011 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.011 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.011 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.011 | |
| macromolecule methylation | GO:0043414 | 120 | 0.011 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.011 | |
| regulation of protein processing | GO:0070613 | 96 | 0.011 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.011 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.011 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.011 | |
| iron ion import into cell | GO:0097459 | 4 | 0.011 | |
| rhythmic process | GO:0048511 | 174 | 0.011 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.011 | |
| purine ribonucleoside biosynthetic process | GO:0046129 | 19 | 0.011 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.011 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.011 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.011 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.011 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.011 | |
| cell cell recognition | GO:0009988 | 44 | 0.011 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.011 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.011 | |
| actin filament polymerization | GO:0030041 | 44 | 0.011 | |
| viral genome replication | GO:0019079 | 17 | 0.011 | Human |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.011 | |
| atp metabolic process | GO:0046034 | 75 | 0.011 | |
| negative regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell | GO:2001189 | 1 | 0.011 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.010 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.010 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.010 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.010 | |
| response to light stimulus | GO:0009416 | 135 | 0.010 | |
| positive regulation of myeloid leukocyte mediated immunity | GO:0002888 | 14 | 0.010 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.010 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.010 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.010 | |
| syncytium formation | GO:0006949 | 43 | 0.010 | |
| striated muscle cell development | GO:0055002 | 125 | 0.010 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.010 | |
| response to metal ion | GO:0010038 | 47 | 0.010 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.010 | |
| autophagy | GO:0006914 | 45 | 0.010 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.010 | |
| feeding behavior | GO:0007631 | 62 | 0.010 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.010 | |
